Copyright Reports & Markets. All rights reserved.

Global Prostate Cancer Diagnostics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Prostate Cancer Diagnostics Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type
    • 1.2.2 Tumor Biomarker Tests
    • 1.2.3 Imaging
    • 1.2.4 Biopsy
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Application
    • 1.3.2 age < 55
    • 1.3.3 age 55-75
    • 1.3.4 age > 75
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Prostate Cancer Diagnostics Market Size Estimates and Forecasts
    • 2.1.1 Global Prostate Cancer Diagnostics Revenue 2015-2026
    • 2.1.2 Global Prostate Cancer Diagnostics Sales 2015-2026
  • 2.2 Prostate Cancer Diagnostics Market Size by Region: 2020 Versus 2026
  • 2.3 Prostate Cancer Diagnostics Sales by Region (2015-2026)
    • 2.3.1 Global Prostate Cancer Diagnostics Sales by Region: 2015-2020
    • 2.3.2 Global Prostate Cancer Diagnostics Sales Forecast by Region (2021-2026)
    • 2.3.3 Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2026)
  • 2.4 Prostate Cancer Diagnostics Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Prostate Cancer Diagnostics Revenue by Region: 2015-2020
    • 2.4.2 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026)
    • 2.4.3 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2026)

3 Global Prostate Cancer Diagnostics by Manufacturers

  • 3.1 Global Top Prostate Cancer Diagnostics Manufacturers by Sales
    • 3.1.1 Global Prostate Cancer Diagnostics Sales by Manufacturer (2015-2020)
    • 3.1.2 Global Prostate Cancer Diagnostics Sales Market Share by Manufacturer (2015-2019)
  • 3.2 Global Top Prostate Cancer Diagnostics Manufacturers by Revenue
    • 3.2.1 Global Prostate Cancer Diagnostics Revenue by Manufacturer (2015-2020)
    • 3.2.2 Global Prostate Cancer Diagnostics Revenue Share by Manufacturer (2015-2020)
  • 3.3 Global Prostate Cancer Diagnostics Price by Manufacturer (2015-2020)
  • 3.4 Competitive Landscape
    • 3.4.1 Key Prostate Cancer Diagnostics Manufacturers Covered: Ranking by Revenue
    • 3.4.2 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI) & (2015-2020)
    • 3.4.3 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.5 Global Prostate Cancer Diagnostics Manufacturing Base Distribution, Product Type
    • 3.5.1 Prostate Cancer Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.5.2 Manufacturers Prostate Cancer Diagnostics Product Type
    • 3.5.3 Date of International Manufacturers Enter into Prostate Cancer Diagnostics Market
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

  • 4.1 Genomic Health
    • 4.1.1 Genomic Health Corporation Information
    • 4.1.2 Genomic Health Description, Business Overview
    • 4.1.3 Genomic Health Prostate Cancer Diagnostics Products Offered
    • 4.1.4 Genomic Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.1.5 Genomic Health Prostate Cancer Diagnostics Revenue by Product
    • 4.1.6 Genomic Health Prostate Cancer Diagnostics Revenue by Application
    • 4.1.7 Genomic Health Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.1.8 Genomic Health Prostate Cancer Diagnostics Revenue by Sales Channel
    • 4.1.9 Genomic Health Recent Development
  • 4.2 Abbott
    • 4.2.1 Abbott Corporation Information
    • 4.2.2 Abbott Description, Business Overview
    • 4.2.3 Abbott Prostate Cancer Diagnostics Products Offered
    • 4.2.4 Abbott Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.2.5 Abbott Prostate Cancer Diagnostics Revenue by Product
    • 4.2.6 Abbott Prostate Cancer Diagnostics Revenue by Application
    • 4.2.7 Abbott Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.2.8 Abbott Prostate Cancer Diagnostics Revenue by Sales Channel
    • 4.2.9 Abbott Recent Development
  • 4.3 OPKO
    • 4.3.1 OPKO Corporation Information
    • 4.3.2 OPKO Description, Business Overview
    • 4.3.3 OPKO Prostate Cancer Diagnostics Products Offered
    • 4.3.4 OPKO Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.3.5 OPKO Prostate Cancer Diagnostics Revenue by Product
    • 4.3.6 OPKO Prostate Cancer Diagnostics Revenue by Application
    • 4.3.7 OPKO Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.3.8 OPKO Prostate Cancer Diagnostics Revenue by Sales Channel
    • 4.3.9 OPKO Recent Development
  • 4.4 Siemens Healthcare
    • 4.4.1 Siemens Healthcare Corporation Information
    • 4.4.2 Siemens Healthcare Description, Business Overview
    • 4.4.3 Siemens Healthcare Prostate Cancer Diagnostics Products Offered
    • 4.4.4 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.4.5 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Product
    • 4.4.6 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Application
    • 4.4.7 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.4.8 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Sales Channel
    • 4.4.9 Siemens Healthcare Recent Development
  • 4.5 DiaSorin
    • 4.5.1 DiaSorin Corporation Information
    • 4.5.2 DiaSorin Description, Business Overview
    • 4.5.3 DiaSorin Prostate Cancer Diagnostics Products Offered
    • 4.5.4 DiaSorin Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.5.5 DiaSorin Prostate Cancer Diagnostics Revenue by Product
    • 4.5.6 DiaSorin Prostate Cancer Diagnostics Revenue by Application
    • 4.5.7 DiaSorin Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.5.8 DiaSorin Prostate Cancer Diagnostics Revenue by Sales Channel
    • 4.5.9 DiaSorin Recent Development
  • 4.6 BioMeriux
    • 4.6.1 BioMeriux Corporation Information
    • 4.6.2 BioMeriux Description, Business Overview
    • 4.6.3 BioMeriux Prostate Cancer Diagnostics Products Offered
    • 4.6.4 BioMeriux Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.6.5 BioMeriux Prostate Cancer Diagnostics Revenue by Product
    • 4.6.6 BioMeriux Prostate Cancer Diagnostics Revenue by Application
    • 4.6.7 BioMeriux Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.6.8 BioMeriux Recent Development
  • 4.7 Roche
    • 4.7.1 Roche Corporation Information
    • 4.7.2 Roche Description, Business Overview
    • 4.7.3 Roche Prostate Cancer Diagnostics Products Offered
    • 4.7.4 Roche Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.7.5 Roche Prostate Cancer Diagnostics Revenue by Product
    • 4.7.6 Roche Prostate Cancer Diagnostics Revenue by Application
    • 4.7.7 Roche Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.7.8 Roche Recent Development
  • 4.8 MDx Health
    • 4.8.1 MDx Health Corporation Information
    • 4.8.2 MDx Health Description, Business Overview
    • 4.8.3 MDx Health Prostate Cancer Diagnostics Products Offered
    • 4.8.4 MDx Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.8.5 MDx Health Prostate Cancer Diagnostics Revenue by Product
    • 4.8.6 MDx Health Prostate Cancer Diagnostics Revenue by Application
    • 4.8.7 MDx Health Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.8.8 MDx Health Recent Development
  • 4.9 Beckman Coulter
    • 4.9.1 Beckman Coulter Corporation Information
    • 4.9.2 Beckman Coulter Description, Business Overview
    • 4.9.3 Beckman Coulter Prostate Cancer Diagnostics Products Offered
    • 4.9.4 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.9.5 Beckman Coulter Prostate Cancer Diagnostics Revenue by Product
    • 4.9.6 Beckman Coulter Prostate Cancer Diagnostics Revenue by Application
    • 4.9.7 Beckman Coulter Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.9.8 Beckman Coulter Recent Development
  • 4.10 Myriad Genetics
    • 4.10.1 Myriad Genetics Corporation Information
    • 4.10.2 Myriad Genetics Description, Business Overview
    • 4.10.3 Myriad Genetics Prostate Cancer Diagnostics Products Offered
    • 4.10.4 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.10.5 Myriad Genetics Prostate Cancer Diagnostics Revenue by Product
    • 4.10.6 Myriad Genetics Prostate Cancer Diagnostics Revenue by Application
    • 4.10.7 Myriad Genetics Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.10.8 Myriad Genetics Recent Development
  • 4.11 Ambry Genetics
    • 4.11.1 Ambry Genetics Corporation Information
    • 4.11.2 Ambry Genetics Description, Business Overview
    • 4.11.3 Ambry Genetics Prostate Cancer Diagnostics Products Offered
    • 4.11.4 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
    • 4.11.5 Ambry Genetics Prostate Cancer Diagnostics Revenue by Product
    • 4.11.6 Ambry Genetics Prostate Cancer Diagnostics Revenue by Application
    • 4.11.7 Ambry Genetics Prostate Cancer Diagnostics Revenue by Geographic Area
    • 4.11.8 Ambry Genetics Recent Development

5 Breakdown Data by Type

  • 5.1 Global Prostate Cancer Diagnostics Sales by Type (2015-2026)
    • 5.1.1 Global Prostate Cancer Diagnostics Sales by Type (2015-2020)
    • 5.1.2 Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2026)
    • 5.1.3 Global Prostate Cancer Diagnostics Sales Market Share by Type (2015-2026)
  • 5.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2015-2026)
    • 5.2.1 Global Prostate Cancer Diagnostics Revenue by Type (2015-2020)
    • 5.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2021-2026)
    • 5.2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2015-2026)
  • 5.3 Prostate Cancer Diagnostics Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

  • 6.1 Global Prostate Cancer Diagnostics Sales by Application (2015-2026)
    • 6.1.1 Global Prostate Cancer Diagnostics Sales by Application (2015-2020)
    • 6.1.2 Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2026)
    • 6.1.3 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2026)
  • 6.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2015-2026)
    • 6.2.1 Global Prostate Cancer Diagnostics Revenue by Application (2015-2020)
    • 6.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2021-2026)
    • 6.2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2026)
  • 6.3 Prostate Cancer Diagnostics Average Selling Price (ASP) by Application (2015-2026)

7 North America

  • 7.1 North America Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
  • 7.2 North America Prostate Cancer Diagnostics Market Facts & Figures by Country
    • 7.2.1 North America Prostate Cancer Diagnostics Sales by Country (2015-2026)
    • 7.2.2 North America Prostate Cancer Diagnostics Revenue by Country (2015-2026)
  • 7.3 North America Prostate Cancer Diagnostics Sales by Type
  • 7.4 North America Prostate Cancer Diagnostics Sales by Application

8 Asia-Pacific

  • 8.1 Asia-Pacific Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
  • 8.2 Asia-Pacific Prostate Cancer Diagnostics Market Facts & Figures by Region
    • 8.2.1 Asia-Pacific Prostate Cancer Diagnostics Sales by Region (2015-2026)
    • 8.2.2 Asia-Pacific Prostate Cancer Diagnostics Revenue by Region (2015-2026)
  • 8.3 Asia-Pacific Prostate Cancer Diagnostics Sales by Type
  • 8.4 Asia-Pacific Prostate Cancer Diagnostics Sales by Application

9 Europe

  • 9.1 Europe Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
  • 9.2 Europe Prostate Cancer Diagnostics Market Facts & Figures by Country
    • 9.2.1 Europe Prostate Cancer Diagnostics Sales by Country (2015-2026)
    • 9.2.2 Europe Prostate Cancer Diagnostics Revenue by Country (2015-2026)
  • 9.3 Europe Prostate Cancer Diagnostics Sales by Type
  • 9.4 Europe Prostate Cancer Diagnostics Sales by Application

10 Latin America

  • 10.1 Latin America Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
  • 10.2 Latin America Prostate Cancer Diagnostics Market Facts & Figures by Country
    • 10.2.1 Latin America Prostate Cancer Diagnostics Sales by Country (2015-2026)
    • 10.2.2 Latin America Prostate Cancer Diagnostics Revenue by Country (2015-2026)
  • 10.3 Latin America Prostate Cancer Diagnostics Sales by Type
  • 10.4 Latin America Prostate Cancer Diagnostics Sales by Application

11 Middle East and Africa

  • 11.1 Middle East and Africa Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Prostate Cancer Diagnostics Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2015-2026)
    • 11.2.2 Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2015-2026)
  • 11.3 Middle East and Africa Prostate Cancer Diagnostics Sales by Type
  • 11.4 Middle East and Africa Prostate Cancer Diagnostics Sales by Application

12 Supply Chain and Sales Channel Analysis

  • 12.1 Prostate Cancer Diagnostics Supply Chain Analysis
  • 12.2 Prostate Cancer Diagnostics Key Raw Materials and Upstream Suppliers
  • 12.3 Prostate Cancer Diagnostics Clients Analysis
  • 12.4 Prostate Cancer Diagnostics Sales Channel and Sales Model Analysis
    • 12.4.1 Prostate Cancer Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 12.4.2 Prostate Cancer Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
    • 12.4.3 Prostate Cancer Diagnostics Distributors

13 Market Dynamics

  • 13.1 Prostate Cancer Diagnostics Market Drivers
  • 13.2 Prostate Cancer Diagnostics Market Opportunities
  • 13.3 Prostate Cancer Diagnostics Market Challenges
  • 13.4 Prostate Cancer Diagnostics Market Restraints
  • 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Prostate Cancer Diagnostics market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Prostate Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

    Segment by Type, the Prostate Cancer Diagnostics market is segmented into
    Tumor Biomarker Tests
    Imaging
    Biopsy
    Other

    Segment by Application, the Prostate Cancer Diagnostics market is segmented into
    age < 55
    age 55-75
    age > 75

    Regional and Country-level Analysis:
    North America
    United States
    Canada
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Southeast Asia
    Australia
    Rest of Asia-Pacific
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic Countries
    Rest of Europe
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    Competitive Landscape and Prostate Cancer Diagnostics Market Share Analysis
    Prostate Cancer Diagnostics market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Prostate Cancer Diagnostics product introduction, recent developments, Prostate Cancer Diagnostics sales by region, type, application and by sales channel.

    The major companies include:
    Genomic Health
    Abbott
    OPKO
    Siemens Healthcare
    DiaSorin
    BioMeriux
    Roche
    MDx Health
    Beckman Coulter
    Myriad Genetics
    Ambry Genetics

    Buy now